As reported by The Los Angeles Times, the World Health Organization is
endorsing blood transfusions from Ebola survivors as a treatment for those currently infected. The idea behind blood transfusion is similar to vaccination by other means, though (at least as discussed here) administered only after a patient has been infected: "The blood plasma of people who have recovered from Ebola contains antibodies that were successful in fighting off the virus. If these antibodies are pumped into an infected person, they might help the recipient fight the disease as well."
The article mentions that while there is little evidence to back the efficacy in preventing Ebola, "Transfusions were used to treat a small number of patients during the 1995 Kikwit Ebola outbreak in Zaire, now known as the Democratic Republic of Congo, according to Dr. Oyewale Tomori, a professor of virology at Redeemer's University in Nigeria. A study published in the Journal of Infectious Diseases after the outbreak reported that eight patients received transfusions, and only one of them died."
The idea of blood transfusions has critics, too: Dr. William Shaffner of Vanderbilt University is skeptical, saying
he was surprised that the WHO would make transfusions a priority in the ongoing crisis because they are labor-intensive, making it difficult to serve a large number of patients.
"You can't do this en masse," Schaffner said. "This is going to be a desperate attempt to provide something for a relatively small number of patients." Finding suitable donors may also prove more challenging than WHO officials expect, he warned. Malnutrition and other health concerns could make it more difficult to draw blood from people. "These are people who have recovered from Ebola," Schaffner said. "When are they hale and hearty enough to actually do a donation?"